Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-060913

Director bought 6,000 shares at $17.40 ($104,400)

From the SEC's structured data for this filing

Trades in this filing

Hoberman Kenneth · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-12 Purchase : show line 1 in the form +6,000 $17.40 $104,400 55,140 D
Open-market purchases · 6,000 sh · avg $17.40 · $104,400
Loading xslF345X03/tm2215423-3_4seq1.xml…